Evidence map›Paper›PMID 39114631›Full record

ArticleFrontiers in toxicology2024

Characterization of a human thyroid microtissue model for testing thyroid disrupting chemicals.

E Rogers, E K Breathwaite, T Nguyen-Jones, S M Anderson, J J Odanga, D T Parks, K K Wolf, T Stone, P Balbuena, J Chen and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

E RogersResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
E K BreathwaiteResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
T Nguyen-JonesResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
S M AndersonResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
J J OdangaResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
D T ParksResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
K K WolfResearch and Development, LifeSciences Division, LifeNet Health, Research Triangle Park, NC, United States.
T StoneResearch and Development, LifeSciences Division, LifeNet Health, Research Triangle Park, NC, United States.
P BalbuenaResearch and Development, LifeSciences Division, LifeNet Health, Research Triangle Park, NC, United States.
J ChenResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
S C PresnellResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
J R WeaverResearch and Development, LifeSciences Division, LifeNet Health, Va Beach, VA, United States.
E L LeCluyseResearch and Development, LifeSciences Division, LifeNet Health, Research Triangle Park, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perturbation of thyroid hormone (T

Indexed as

endocrine disruptionhypothyroidismmicrotissuesTDCthyrocytethyroglobulinthyroidthyroxine

Identifiers

PMID39114631
PMCPMC11303298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.